Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality

Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study

(2017) Sigrid Carlsson et al.   EUROPEAN UROLOGY

Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer

(2016) Tuomas P. Kilpeläinen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities

(2016) Idris Guessous et al.   PREVENTIVE MEDICINE

Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

(2015) Rebecka Arnsrud Godtman et al.   EUROPEAN UROLOGY

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

(2015) Ahmedin Jemal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial

(2013) Anna Grenabo Bergdahl et al.   EUROPEAN UROLOGY

Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

(2013) Monique J. Roobol et al.   EUROPEAN UROLOGY

Prostate Cancer Mortality in the Finnish Randomized Screening Trial

(2013) T. P. Kilpelainen et al.   JNCI-Journal of the National Cancer Institute

Socioeconomic Variation and Prostate Specific Antigen Testing in the Community: A United Kingdom Based Population Study

(2013) Rhian M. Morgan et al.   JOURNAL OF UROLOGY

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

(2012) Tobias Nordström et al.   EUROPEAN UROLOGY

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer

(2011) Anders Berglund et al.   EUROPEAN JOURNAL OF CANCER

Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States

(2011) Michael W. Drazer et al.   JOURNAL OF CLINICAL ONCOLOGY

ERSPC and PLCO Prostate Cancer Screening Studies: What Are the Differences?

(2010) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program

(2010) L. Palencia et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: A review

(2010) Teresa Spadea et al.   PREVENTIVE MEDICINE

Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis

(2009) Elisabetta Rapiti et al.   CANCER